LivaNova PLC (LIVN)
NASDAQ
Closed
Aug 24, 2026
Day's Range
78.0352 wk Range
48.82Overview - LIVN - LivaNova PLC
Key Statistics
Valuation
Enterprise Value
4.17B
P/E (Trailing)
‪23.22‬
P/E (Forward)
‪16.83‬
PEG Ratio
‪0.07‬
Price / Sales (TTM)
‪2.93‬
Price / Book
‪3.27‬
EV / EBITDA
‪15.58‬
Profitability
Gross Margin
‪70.06%‬
Profit Margin
‪12.81%‬
Operating Margin
‪15.51%‬
Return on Assets
‪5.22%‬
Return on Equity
‪15.40%‬
Ownership
Shares Outstanding
55.05M
Float
54.82M
Short % of Shares Outstanding
‪8.64%‬
Held by Insiders
‪0.41%‬
Held by Institutions
‪113.18%‬
Price stats
Beta
‪0.87‬
50-Day Avg
‪80.49‬
200-Day Avg
‪68.42‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
10 analysts
Average price target
‪$ 88.80‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LIVN - LivaNova PLC
Peers - LIVN - LivaNova PLC
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
- LILIVNNASDAQLivaNova PLC4.32BMarket Cap+28.43%52-week change23.23P/E (Trailing)‪12.81%‬Profit Margin
- DXCMNASDAQDexCom, Inc.34.84BMarket Cap+17.74%52-week change37.38P/E (Trailing)‪20.11%‬Profit Margin
- GEHCNASDAQGE HealthCare Technologies Inc.33.79BMarket Cap+0.31%52-week change17.24P/E (Trailing)‪9.33%‬Profit Margin
- PODDNASDAQInsulet Corporation10.27BMarket Cap-122.06%52-week change27.80P/E (Trailing)‪12.29%‬Profit Margin
- TLTNASDAQiShares 20+ Year Treasury Bond ETF9.46BMarket Cap-5.03%52-week change—P/E (Trailing)—Profit Margin
- BRKRNASDAQBruker Corporation9.07BMarket Cap+41.89%52-week change74.88P/E (Trailing)‪-2.03%‬Profit Margin
- IRTCNASDAQIrhythm Technologies Inc.4.23BMarket Cap-28.91%52-week change-92.51P/E (Trailing)‪-1.69%‬Profit Margin
Profile Summary - LIVN - LivaNova PLC
About
LivaNova is a global medical technology company that develops innovative devices and therapies for cardiac surgery, cardiopulmonary support, and neuromodulation treatments. The company's primary product portfolio includes vagus nerve stimulation therapy for drug-resistant epilepsy and difficult-to-treat depression,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
